In this study, we evaluated the change in left ventricular end-diastolic pressure (LVEDP) after primary percutaneous coronary intervention (PCI) and its impact on in-hospital outcomes and 30-day and three-month quality of life (SAQ-7), ejection fraction (EF), and major adverse cardiovascular events (MACE). LVEDP ≥19 mmHg was taken as elevated LVEDP. In a sample of 318 patients, 18.9% (n=60) were females and mean age was 55.7 ± 10.52 years. Post-procedure elevated LVEDP was observed in 20.8% (n=66) with a mean reduction of 1.65 ± 4.35 mmHg. LVEDP declined in 39% (n=124) and increased in 10.7% (n=34). In-hospital mortality rate (9.1% 2.4%, p=0.011), 30-day MACE (9.1% 4.0%), and three-month MACE (21.2% 5.6%) were found to be significantly higher among patients with elevated LVEDP, respectively. Elevated LVEDP was found to be associated with a reduced SAQ-7 score (89.84 ± 8.09 92.29 ± 3.03, p<0.001) and reduced (25-40%) EF (55.6% 22.6%) at three-month follow-up. LVEDP declined acutely in a significant number of patients after primary PCI. Post- procedure elevated LVEDP was found to be associated with poor quality of life and an increased risk of immediate and short-term MACE.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11376260 | PMC |
http://dx.doi.org/10.5837/bjc.2023.043 | DOI Listing |
Indian Heart J
December 2024
Division of Epidemiology & Biostatistics, National Institute of Epidemiology, Indian Council of Medical Research (ICMR), Chennai, Tamil Nadu, India.
Objectives: The objective of this study was to assess the clinical, hemodynamic characteristics and immediate outcomes of Percutaneous Balloon Mitral Valvotomy (PBMV) in low gradient severe rheumatic mitral stenosis (LGMS) with normal cardiac index.
Background: The optimal management of LGMS remains incompletely understood.
Methods: We examined 200 consecutive patients with severe rheumatic mitral stenosis (MS) who underwent PBMV between January 2014 and March 2020.
Open Life Sci
November 2024
Department of General Practice, Shandong ZiBo Central Hospital, Zibo, 255036, Shandong, China.
Sci Rep
November 2024
Department of Ultrasound, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, No. 167 Beilishi Road, Beijing, 100037, China.
Current guideline for evaluating diastolic function requires multiple parameters to identify patients with elevated left ventricular end-diastolic pressure (LVEDP). However, the intermediate result still exists and may cause LVEDP undetermined. Previous studies have shown intraventricular pressure difference (IVPDs) are required for normal LV filling, but the relationship between IVPDs and LVEDP is unknown.
View Article and Find Full Text PDFCardiovasc Diagn Ther
October 2024
Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA.
Background: Left ventricular end-diastolic pressure (LVEDP) is a key indicator of cardiac health. The gold-standard method of measuring LVEDP is invasive intra-cardiac catheterization. Echocardiography is used for non-invasive estimation of left ventricular (LV) filling pressures; however, correlation with invasive LVEDP is variable.
View Article and Find Full Text PDFAm J Med Genet A
February 2025
Divisions of Medical Genetics and Cardiology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!